Linked Life Data

17593245

Source:http://linkedlifedata.com/resource/pubmed/id/17593245

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2007-8-29
pubmed:abstractText
To determine the cost-effectiveness of adding pioglitazone to existing treatment regimens in patients with Type 2 diabetes with a history of macrovascular disease who are at high risk of further cardiovascular events.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0742-3071
pubmed:author
pubmed:issnType
Print
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
982-1002
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK.
pubmed:affiliation
Center for Outcomes Research, A Unit of IMS Health, Allschwil, Switzerland.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't